|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 9/12 | (2006.01) |
| (11) | Number of the document | 1531794 |
| (13) | Kind of document | T |
| (96) | European patent application number | 03742233.4 |
| Date of filing the European patent application | 2003-06-26 | |
| (97) | Date of publication of the European application | 2005-05-25 |
| (45) | Date of publication and mention of the grant of the patent | 2017-05-10 |
| (46) | Date of publication of the claims translation | 2017-08-25 |
| (86) | Number | PCT/US2003/020166 |
| Date | 2003-06-26 |
| (87) | Number | WO 2004/002551 |
| Date | 2004-01-08 |
| (30) | Number | Date | Country code |
| 393007 P | 2002-06-28 | US | |
| 393716 P | 2002-07-02 | US | |
| 425349 P | 2002-11-08 | US |
| (72) |
BATYCKY, Richard, P., US
CAPONETTI, Giovanni, IT
CHILDS, Mariko, US
EHRICH, Elliot, US
FU, Karen, US
HRKACH, Jeffrey, S., US
LI, Wen-I, US
LIPP, Michael, M., US
PAN, Mei-Ling, US
SUMMA, Jason, US
|
| (73) |
Civitas Therapeutics, Inc.,
190 Everett Ave., Chelsea, MA 02150,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Inhaliuojamas epinefrinas |
| INHALABLE EPINEPHRINE |
| Payment date | Validity (years) | Amount | |
| 2022-06-23 | 347.00 EUR |